Business Wire

RAW Nutrition Joins Forces with The Quality Group in Category-Defining Co-Ownership and Partnership

1.4.2025 16:00:00 EEST | Business Wire | Press release

Share

RAW Nutrition, the fast growing sport nutrition brand that combines unmatched quality with cutting-edge formulation, today announced its partnership with The Quality Group, the European leader in performance nutrition known for its state-of-the-art product development and uncompromising quality standards. RAW Nutrition, which was recognized in 2024 as the fastest-growing consumer packaged goods company by Inc. 5000, built its reputation by delivering high-performance nutrition trusted by athletes at the highest level, and this strategic partnership allows the company to take that commitment to growth and innovation to the next level.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250401643282/en/

RAW Nutrition Joins Forces with The Quality Group in Category-Defining Co-Ownership and Partnership

This alliance combines two like-minded companies that emphasize a shared priority of delivering the highest standards in quality and innovation in the nutrition sector. The Quality Group, with its two leading brands, ESN and More Nutrition, brings in its proven expertise in cutting-edge production and quality, supporting RAW Nutrition in sustainably scaling its brand.

Both companies share a strong focus on community and athletes. As part of this shared commitment, Chris Bumstead – Co-Owner of RAW Nutrition, six-time Mr. Olympia, and one of the most recognized names in the fitness world – will be working closely with The Quality Group to share his expertise in developing high-quality products that athletes and everyday consumers can benefit from. Chris’ second brand, BUM Energy – a dynamic energy drink label – will also become part of The Quality Group’s partnership portfolio.

“After many discussions with several global performance nutrition companies, we decided to enter a partnership with The Quality Group given that they understand all the opportunities and challenges that we’re about to face, and have navigated through them extremely successfully,” said Dom Iacovone, RAW Nutrition Co-Founder and CEO. “Going through our process, it was very important to me to find a strategic partner versus one that would just give us the most money. We have big goals at RAW Nutrition to build this brand as big as it can be and cooperating with The Quality Group is the first step to helping us navigate that.”

RAW Nutrition & The Quality Group: A New Chapter

Effective immediately, RAW Nutrition’s CEO and Co-Founder, Dom Iacovone, and co-owner Chris Bumstead will both become co-owners of The Quality Group.

In the coming months, RAW Nutrition will focus on growing their product offering and presence in the US market, reaching current and new consumers in new ways.

"Both RAW Nutrition and The Quality Group are rooted in strong communities,” said Heikki Takala, CEO of The Quality Group. “Just as RAW Nutrition engages and fuels athletes in the US, The Quality Group’s brands ESN and More Nutrition engage and enable a loyal, performance-driven customer base in Europe. This strategic partnership enables us to elevate our commitment to our communities, and we are excited to get to join forces with Dom and Chris Bumstead, who are successful entrepreneurs. Chris is a true global icon in our industry, and we believe this is great news for our community.”

RAW Nutrition and The Quality Group will remain independent partners as they seek to build long-term value for their consumers. Lazard acted as financial advisor and Fredrikson & Byron P.A. acted as legal advisor to RAW Nutrition.

What is RAW Nutrition

RAW Nutrition combines unmatched quality with cutting-edge formulation to provide athletes with the best fuel for peak performance, recovery, and overall well-being.

Product Snapshot:

  • CBUM Itholate Protein (MSRP $54.99): Formulated by Chris Bumstead himself, this 25g pure whey isolate blend is engineered for lean muscle growth and rapid recovery.
  • Creatine Monohydrate (MSRP $12.99): Spikes strength, generates muscular power, and improves muscle fullness.
  • Essential Pre-Workout(MSRP $26.99): A powerhouse formula designed for all lifters from beginner to advanced, packing 4g L-Citrulline for serious pumps and 3.2g Beta Alanine to delay fatigue.
  • RAW Grass Fed Whey Protein(MSRP: $49.49): Pure, grass-fed whey protein isolate, this high-quality, fast-digestive 25g protein powder supports muscle growth and recovery.
  • Ready to Drink Protein Shake(MSRP $4.25): Raw Nutrition’s top-selling protein in a ready-to-drink format. 30g micro-filtered, grass-fed protein isolate, no fillers, no dyes—just pure fuel on the go.

To shop RAW Nutrition’s products or to learn more, visit getrawnutrition.com, or follow them on Instagram, LinkedIn, TikTok or YouTube.

About RAW Nutrition

RAW Nutrition is led by Dr. Domenic Iacovone, six-time Classic Physique Mr. Olympia Champion Chris Bumstead, and renowned bodybuilding coach Matt Jansen.Since its inception in 2019, RAW Nutrition has been recognized as the #1 fastest-growing sports nutrition company by Inc. 5000 and was named Brand of the Year by GNC and Vitamin Shoppe. All RAW Nutrition products are made with premium, clean ingredients, free from unnecessary fillers and additives. RAW Nutrition proudly carries the Informed-Sport certification, a mark of excellence that guarantees its products are rigorously tested for prohibited substances.

About The Quality Group

The Quality Group is the leading sports nutrition, supplements and health food company based in Germany. The company operates a unique digital direct-to-consumer & social commerce business model with its own production, logistics and technology. The two brands "ESN" and "More Nutrition" are strongly rooted in their respective communities and offer better-for-you and performance nutrition to help their customers to live a better life and achieve their personal goals. The Quality Group is headquartered in Elmshorn and employs more than 1.200 people. In 2023, the company generated revenues of more than EUR 680 million. The Quality Group is owned by its founders, an experienced management team and CVC Capital Partners, one of the leading Private Equity companies globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250401643282/en/

Contacts

Press Contact
Taylor Georgeson
Jack Taylor PR
raw@jacktaylorpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool1.4.2026 13:17:00 EEST | Press release

Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today. Huawei, LG Electronics and Nokia have made their standard essential patents (SEPs) reading on cellularly connected POS devices available through the programme, so simplifying access to the increasingly ubiquitous technology. Early participation incentives for licensors to join the pool are available until mid-May. Other cellular patent owners not currently in discussions with Sisvel are encouraged to get in touch. Ranging from handheld card machines to tablet-based registers, POS devices have transformed customer payment processing. Increasingly, they also offer enhanced capabilities such as inventory management, real-time tracking, advanced analytics and automatic re-ordering. Standardised cellular technology is the critical feature that enables POS terminals to function wherever customers are located. The Sisvel POS programm

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 12:11:00 EEST | Press release

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechnology executive, bringing over two decades of therapeutic and diagnostic R&D experience within industry to Mosaic Therapeutics, with a track record spanning from IND through to NDA/BLA/MAA approval. Most recently he served at BioXcel Therapeutics as EVP, Head of Product Developme

The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 10:00:00 EEST | Press release

The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights - equipping executives with the perspective needed to make confident, high-stakes decisions. “Through our work we increasingly s

Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 09:00:00 EEST | Press release

As millions of Europeans2 get ready to enjoy the Easter weekend, new research from Samsung finds Europe’s public spaces have become shared screens: 56% of people say they have accidentally looked at a stranger’s phone, citing public transport as the most likely place to notice someone else’s screen (57%). Nearly one in four Europeans2 (24%) admit to looking at someone else’s phone out of curiosity, exposing a stream of private content from personal photos to bank details. Samsung Electronics surveyed 11,000 Europeans2 to support the launch of the Galaxy S26 Ultra, which introduces a built-in Privacy Display. This new hardware-based technology keeps screen content visible only from the front to protect privacy from side angles, without compromising the viewing experience3. The study further reveals a gap between perceived phone privacy and reality: While 48%* feel their own phone use is private when using it in crowded places, 52%** find it easy to view someone else’s screen in public.

RevolKa Reimagines Antibody Engineering with "RevoAb ® "1.4.2026 07:30:00 EEST | Press release

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allows researchers worldwide to experience RevolKa’s high-performance antibody design. Key Advantages of RevoAb® Speed: Multiple optimi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye